Loading…
Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I
Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in co...
Saved in:
Published in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 1999-09, Vol.34 (3), p.525-530 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23 |
---|---|
cites | cdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23 |
container_end_page | 530 |
container_issue | 3 |
container_start_page | 525 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 34 |
creator | Inoue, Kiyo Nishimura, Hikaru Kubota, Jiro Kawamura, Keishiro |
description | Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (>10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase. |
doi_str_mv | 10.1161/01.HYP.34.3.525 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70039832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70039832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</originalsourceid><addsrcrecordid>eNpVkUFv1DAQhS0EokvhzA35gLgl9diTOD6uVi27UqVWqEVwshyv0w0kdrETqv33eNmVoCONRjPzzTu8IeQ9sBKghgsG5fr7bSmwFGXFqxdkARXHAqtavCQLBgoLBfDtjLxJ6QdjgIjyNTkDho1CVi3IuBwmF72Z-t-OLv1DHybnU-_pZkOvQhzzInia-y9mosuY2d4lemPtHHPxw57m-VcX93TdP-zoKnjr_BT_niUauueab8mrzgzJvTvVc3J_dXm3WhfXN583q-V1YRGVKhy0vJWiUdzYrWla6xBaCUZua8FN2zqspeTAjDDObCWoDjvZQVtntlKWi3Py6aj7GMOv2aVJj32ybhiMd2FOWjImVCMO4MURtDGkFF2nH2M_mrjXwPTBYc1AZ4e1QC10djhffDhJz-3otv_xR0sz8PEEmGTN0EXjbZ_-capBhgcMj9hTOHwg_RzmJxf1zplh2mmWA3ndFKCUYip3RU6uxB97l5Qk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70039832</pqid></control><display><type>article</type><title>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</title><source>EZB Electronic Journals Library</source><creator>Inoue, Kiyo ; Nishimura, Hikaru ; Kubota, Jiro ; Kawamura, Keishiro</creator><creatorcontrib>Inoue, Kiyo ; Nishimura, Hikaru ; Kubota, Jiro ; Kawamura, Keishiro</creatorcontrib><description>Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (>10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.34.3.525</identifier><identifier>PMID: 10489405</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Angiotensin I - analogs & derivatives ; Angiotensin I - metabolism ; Angiotensin I - pharmacology ; Angiotensin II - drug effects ; Angiotensin II - metabolism ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Antihypertensive Agents - pharmacology ; Aorta - drug effects ; Aorta - metabolism ; Arteries - drug effects ; Arteries - metabolism ; Benzimidazoles - pharmacology ; Biological and medical sciences ; Blood vessels and receptors ; Carotid Arteries - drug effects ; Carotid Arteries - metabolism ; Cricetinae ; Fundamental and applied biological sciences. Psychology ; Male ; Mesocricetus ; Pressoreceptors - drug effects ; Rats ; Rats, Inbred WKY ; Serine Proteinase Inhibitors - pharmacology ; Tetrazoles - pharmacology ; Time Factors ; Vasoconstriction - drug effects ; Vertebrates: cardiovascular system</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1999-09, Vol.34 (3), p.525-530</ispartof><rights>1999 American Heart Association, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</citedby><cites>FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1984045$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10489405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inoue, Kiyo</creatorcontrib><creatorcontrib>Nishimura, Hikaru</creatorcontrib><creatorcontrib>Kubota, Jiro</creatorcontrib><creatorcontrib>Kawamura, Keishiro</creatorcontrib><title>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (>10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.</description><subject>Angiotensin I - analogs & derivatives</subject><subject>Angiotensin I - metabolism</subject><subject>Angiotensin I - pharmacology</subject><subject>Angiotensin II - drug effects</subject><subject>Angiotensin II - metabolism</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Aorta - drug effects</subject><subject>Aorta - metabolism</subject><subject>Arteries - drug effects</subject><subject>Arteries - metabolism</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood vessels and receptors</subject><subject>Carotid Arteries - drug effects</subject><subject>Carotid Arteries - metabolism</subject><subject>Cricetinae</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Male</subject><subject>Mesocricetus</subject><subject>Pressoreceptors - drug effects</subject><subject>Rats</subject><subject>Rats, Inbred WKY</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><subject>Tetrazoles - pharmacology</subject><subject>Time Factors</subject><subject>Vasoconstriction - drug effects</subject><subject>Vertebrates: cardiovascular system</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpVkUFv1DAQhS0EokvhzA35gLgl9diTOD6uVi27UqVWqEVwshyv0w0kdrETqv33eNmVoCONRjPzzTu8IeQ9sBKghgsG5fr7bSmwFGXFqxdkARXHAqtavCQLBgoLBfDtjLxJ6QdjgIjyNTkDho1CVi3IuBwmF72Z-t-OLv1DHybnU-_pZkOvQhzzInia-y9mosuY2d4lemPtHHPxw57m-VcX93TdP-zoKnjr_BT_niUauueab8mrzgzJvTvVc3J_dXm3WhfXN583q-V1YRGVKhy0vJWiUdzYrWla6xBaCUZua8FN2zqspeTAjDDObCWoDjvZQVtntlKWi3Py6aj7GMOv2aVJj32ybhiMd2FOWjImVCMO4MURtDGkFF2nH2M_mrjXwPTBYc1AZ4e1QC10djhffDhJz-3otv_xR0sz8PEEmGTN0EXjbZ_-capBhgcMj9hTOHwg_RzmJxf1zplh2mmWA3ndFKCUYip3RU6uxB97l5Qk</recordid><startdate>199909</startdate><enddate>199909</enddate><creator>Inoue, Kiyo</creator><creator>Nishimura, Hikaru</creator><creator>Kubota, Jiro</creator><creator>Kawamura, Keishiro</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199909</creationdate><title>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</title><author>Inoue, Kiyo ; Nishimura, Hikaru ; Kubota, Jiro ; Kawamura, Keishiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Angiotensin I - analogs & derivatives</topic><topic>Angiotensin I - metabolism</topic><topic>Angiotensin I - pharmacology</topic><topic>Angiotensin II - drug effects</topic><topic>Angiotensin II - metabolism</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Aorta - drug effects</topic><topic>Aorta - metabolism</topic><topic>Arteries - drug effects</topic><topic>Arteries - metabolism</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood vessels and receptors</topic><topic>Carotid Arteries - drug effects</topic><topic>Carotid Arteries - metabolism</topic><topic>Cricetinae</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Male</topic><topic>Mesocricetus</topic><topic>Pressoreceptors - drug effects</topic><topic>Rats</topic><topic>Rats, Inbred WKY</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><topic>Tetrazoles - pharmacology</topic><topic>Time Factors</topic><topic>Vasoconstriction - drug effects</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inoue, Kiyo</creatorcontrib><creatorcontrib>Nishimura, Hikaru</creatorcontrib><creatorcontrib>Kubota, Jiro</creatorcontrib><creatorcontrib>Kawamura, Keishiro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inoue, Kiyo</au><au>Nishimura, Hikaru</au><au>Kubota, Jiro</au><au>Kawamura, Keishiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1999-09</date><risdate>1999</risdate><volume>34</volume><issue>3</issue><spage>525</spage><epage>530</epage><pages>525-530</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (>10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>10489405</pmid><doi>10.1161/01.HYP.34.3.525</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 1999-09, Vol.34 (3), p.525-530 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_70039832 |
source | EZB Electronic Journals Library |
subjects | Angiotensin I - analogs & derivatives Angiotensin I - metabolism Angiotensin I - pharmacology Angiotensin II - drug effects Angiotensin II - metabolism Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Antihypertensive Agents - pharmacology Aorta - drug effects Aorta - metabolism Arteries - drug effects Arteries - metabolism Benzimidazoles - pharmacology Biological and medical sciences Blood vessels and receptors Carotid Arteries - drug effects Carotid Arteries - metabolism Cricetinae Fundamental and applied biological sciences. Psychology Male Mesocricetus Pressoreceptors - drug effects Rats Rats, Inbred WKY Serine Proteinase Inhibitors - pharmacology Tetrazoles - pharmacology Time Factors Vasoconstriction - drug effects Vertebrates: cardiovascular system |
title | Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20Angiotensin%20II%20Formation%20in%20Rat%20Arteries%20Occurs%20Only%20at%20Very%20High%20Concentrations%20of%20Angiotensin%20I&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Inoue,%20Kiyo&rft.date=1999-09&rft.volume=34&rft.issue=3&rft.spage=525&rft.epage=530&rft.pages=525-530&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.34.3.525&rft_dat=%3Cproquest_cross%3E70039832%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70039832&rft_id=info:pmid/10489405&rfr_iscdi=true |